Trial Profile
Radiosurgery and Avastin for Recurrent Malignant Gliomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioma
- Focus Adverse reactions
- 21 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 21 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2011 Planned end date changed from 1 Jul 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.